as on March 4, 2026 at 6:12 am IST
Day's Low
Day's High
2.11%
Downside
1.95%
Upside
52 Week's Low
52 Week's High
37.69%
Downside
44.61%
Upside
Check Madrigal Pharmaceuticals, Inc. market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.
Market Cap
$9.8B
EPS (TTM)
-5.7275
Dividend Yield
0.00%
Quarterly Earnings Growth YOY
0.00%
PE Ratio (TTM)
0PEG Ratio
0EBITDA
-298.6M
Revenue (TTM)
958.4M
Profit Margin
-30.08%
Return On Equity TTM
-42.49%
Compare market cap, revenue, PE, and other key metrics of Madrigal Pharmaceuticals, Inc. with its industry peers.
Company | Analyst View | Market Cap | 5 Years Return % | PE Ratio | Profit Margin % |
|---|---|---|---|---|---|
| BUY | $9.8B | 288.53% | NA | -30.08% | |
| BUY | $126.2B | 133.18% | 32.47 | 32.94% | |
| BUY | $44.2B | 125.24% | 142.88 | 8.45% | |
| NA | $35.1B | NA | 621.55 | 5.37% | |
| BUY | $82.6B | 77.02% | 18.83 | 31.41% |
The Madrigal Pharmaceuticals, Inc. stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.
*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.
Investment Value
₹1,00,000
Madrigal Pharmaceuticals, Inc. investment value today
Current value as on today
₹1,41,170
Returns
₹41,170
(+41.17%)
Returns from Madrigal Pharmaceuticals, Inc. Stock
₹35,665 (+35.67%)
Dollar Returns*
₹5,505 (+5.5%)
Based on 21 analysts
80.95%
Buy
14.29%
Hold
4.76%
Sell
Based on 21 analysts, 80.95% of analysts recommend a 'BUY' rating for Madrigal Pharmaceuticals, Inc.. Average target price of $667.57
Get share price movements and forecasts by analysts on Madrigal Pharmaceuticals, Inc..
What analysts predicted
36.3%UPSIDE
Target Price
$667.57
Current Price
$425.27
Analyzed by
21 Analysts
Target
$667.57
Madrigal Pharmaceuticals, Inc. target price $667.57, a slight upside of 36.3% compared to current price of $425.27. According to 21 analysts rating.
Search interest for Madrigal Pharmaceuticals, Inc. Stock has decreased by -54% in the last 30 days, reflecting a downward trend in search activity.
Time period: to
All numbers in Millions USD
All numbers in Millions USD
All numbers in Millions USD
All numbers in Millions USD
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
Best in 1 Year
![]()
In the last 1 year, MDGL has outperformed top 5 stocks with highest market-cap in its industry
Against Peers
![]()
In the last 3 years, Vertex Pharmaceuticals Incorporated has given 60.5% return, outperforming this stock by 0.5%
Price Dip
![]()
In the last 3 months, MDGL stock has moved down by -24.9%
| Organisation | Madrigal Pharmaceuticals, Inc. |
| Headquarters | Four Tower Bridge, West Conshohocken, PA, United States, 19428 |
| Industry | Health Technology |
| CEO | Mr. William J. Sibold |
| E-voting on shares | Click here to vote |
Name | Title |
|---|---|
Mr. William J. Sibold | CEO, President & Director |
Dr. Rebecca A. Taub M.D. | Founder, Senior Scientific & Medical Advisor and Director |
Ms. Mardi C. Dier | Executive VP & CFO |
Ms. Carole Huntsman | Executive VP & Chief Commercial Officer |
Mr. Mark Underwood | Executive Vice President of Business Planning & Operations |
Ms. Rita Thakkar | Senior VP & Chief Accounting Officer |
Mr. Ronald Filippo | Executive VP & Chief Information Officer |
Mr. Clint Wallace | Executive VP & Chief Human Resources Officer |
Ms. Shannon Kelley | Executive VP, Chief Legal Officer & Corporate Secretary |
Ms. Tina E. Ventura | Chief Investor Relations Officer |
Madrigal Pharmaceuticals, Inc. share price today is $425.27 as on . Madrigal Pharmaceuticals, Inc. share today touched a day high of $433.56 and a low of $416.3.
Madrigal Pharmaceuticals, Inc. share touched a 52 week high of $615 on and a 52 week low of $265 on . Madrigal Pharmaceuticals, Inc. stock price today i.e. is trending at $425.27,which is 30.85% down from its 52 week high and 60.48% up from its 52 week low.
Madrigal Pharmaceuticals, Inc. market capitalisation is $0.01T as on .
Indian investors can start investing in Madrigal Pharmaceuticals, Inc. (MDGL) shares with as little as ₹92.074 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹920.74 in Madrigal Pharmaceuticals, Inc. stock (as per the Rupee-Dollar exchange rate as on ).
Based on Madrigal Pharmaceuticals, Inc. share’s latest price of $425.27 as on March 4, 2026 at 12:42 am IST, you will get 0.0235 shares of Madrigal Pharmaceuticals, Inc.. Learn more about
fractional shares .
Madrigal Pharmaceuticals, Inc. stock has given 288.53% share price returns and 25.56% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?